Psoriasis, a pesky skin condition that many thought was just a nuisance, has a darker side that could threaten vision. Yeah, you heard that right. It turns out that psoriasis isn’t just about those red, scaly patches. Research shows it’s linked to a whopping 56% higher risk of age-related macular degeneration (AMD) compared to folks struggling with major depressive disorder.
And if you think that’s bad, psoriasis patients also face a 21% increase in AMD risk compared to those with benign melanocytic nevi. Both forms of AMD—wet and dry—are elevated in psoriasis cases, but watch out for the wet form, which can cause rapid vision loss. It’s like a bad horror movie, but with your eyesight on the line.
Now here’s where things get interesting. Biologics, those fancy treatments for psoriasis, have been shown to reduce AMD risk by 27% when stacked against topical corticosteroids. Not only do these biologics help the skin, but they also show promise in protecting the eyes. Both wet and dry forms of AMD are linked to psoriasis, which is a surprising connection. Moreover, lipid dysregulation may play a significant role in the connection between psoriasis and AMD, indicating a complex interplay between these conditions.
Biologics not only tackle psoriasis but also cut AMD risk by 27%. Who knew skin treatments could protect your eyes too?
Even better, these treatments cut down on ocular surface and corneal inflammation risks, and the benefits can last from six months to ten years. That’s a win-win, right?
But hold your horses. This isn’t a magic bullet. The research, presented at the European Academy of Dermatology and Venereology Congress 2025, has its share of limitations. They used retrospective data, which can be as slippery as a greased pig.
Plus, they didn’t report any hazard ratios or absolute rates. So, while the findings are eye-opening (pun intended), they come with a side of caution.
In the grand scheme, it’s clear that psoriasis is a systemic inflammatory beast with potential ocular complications. The link between lipid dysregulation in psoriasis and dry AMD is still being explored. Future studies could shed light on this connection, but for now, the message is loud and clear: psoriasis isn’t just skin deep.
